Assignee

Seres Therapeutics, Inc.

Patents = 27

Trademarks = 13

Forward Citations = 444

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

23 inventors (with patents filed for the assignee):

Seres Therapeutics, Inc. is a leading biotechnology company focused on developing innovative microbiome therapeutics. The company is dedicated to creating effective solutions for serious diseases using a deep understanding of microbiome science. Seres' cutting-edge research and development efforts aim to harness the power of the human microbiome to transform outcomes for patients in need. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com